Corporate Boards

The Scientist, Jan. 10, 1994, page 21): Sheldon Krimsky appears to take the view that if a scientist serves on a board, he or she is guilty until proved innocent. What is the scientist guilty of? The litany includes: (1) not being interested in seeking the truth, as academic purists are, and (2) having a clear conflict of interest if evaluating research, whether the company's or others', in any peer review related to the company's in

Written byIrving Johnson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Krimsky goes on to claim that if a scientist feels compelled to join a board, he or she must agree "never to take any government- funded research projects that are directly related to any work in the company." In fact, some National Institutes of Health research is funded in small companies.

Krimsky's concerns seem embedded in the belief that once in contact with a commercial firm, all scientists become dishonest and incapable of any impartial action.

I believe it is precisely because of researchers' objectivity and ability to evaluate science in an increasingly complex and technologically driven world that their expertise not only is required on boards, but also is almost a necessity to protect the investment required to bring the benefits of discovery from the laboratory to the public. As with any other human endeavor, it is not a perfect world. Nobel laureates are sometimes used as "window dressing," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery